Spots Global Cancer Trial Database for quality of life (qol)
Every month we try and update this database with for quality of life (qol) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Hyperbaric Oxygenation Treatment and Quality of Life | NCT03570229 | Cancer | Hyperbaric oxyg... | - | University of Bergen | |
Hyperbaric Oxygenation Treatment and Quality of Life | NCT03570229 | Cancer | Hyperbaric oxyg... | - | University of Bergen | |
Breast Cancer & Antiestrogenic Therapy & Brain | NCT06346457 | Breast Cancer F... Healthy Female Menopause Anti-estrogenic... | Tamoxifen Letrozole Letrozole + GnR... | 18 Years - 70 Years | International Research Training Group 2804 | |
Prostate Boost Irradiation With Stereotactic Body RT (SBRT) | NCT03380806 | Prostate Cancer | LHRH agonist Pelvic Radiatio... Stereotactic Bo... Conventional Ra... | 18 Years - 85 Years | Juravinski Cancer Center | |
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors | NCT03326973 | Metastatic Mela... | EuroQoL EQ-5D-3... EORTC QLQ-C30 PRO-CTCAE Fatigue severit... The COST Physician infor... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Prostate Boost Irradiation With Stereotactic Body RT (SBRT) | NCT03380806 | Prostate Cancer | LHRH agonist Pelvic Radiatio... Stereotactic Bo... Conventional Ra... | 18 Years - 85 Years | Juravinski Cancer Center | |
Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary | NCT06274190 | Rectal Cancer LARS - Low Ante... | bowel e-diary | 18 Years - | KU Leuven | |
Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary | NCT06274190 | Rectal Cancer LARS - Low Ante... | bowel e-diary | 18 Years - | KU Leuven | |
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | NCT01888198 | Renal Cancer | (EORTC QLQ-C30)... EuroQol EQ-5D 7... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors | NCT03326973 | Metastatic Mela... | EuroQoL EQ-5D-3... EORTC QLQ-C30 PRO-CTCAE Fatigue severit... The COST Physician infor... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience | NCT03430492 | Breast Cancer | 18 Years - | Lund University | ||
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | NCT01888198 | Renal Cancer | (EORTC QLQ-C30)... EuroQol EQ-5D 7... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Physical Training in Glioblastoma Patients During Cytotoxic Therapy | NCT05015543 | Glioblastoma | Personal Traini... | 18 Years - | University Hospital Muenster | |
A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma | NCT04831658 | Primary Central... | the dose-escala... | 18 Years - 69 Years | Zhengzhou University | |
A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma | NCT04831658 | Primary Central... | the dose-escala... | 18 Years - 69 Years | Zhengzhou University | |
Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy | NCT05101759 | Neoplasm, Plasm... Lymphoma | Comprehensive G... | 75 Years - | University Hospital, Toulouse |